share_log

Chardan Capital Maintains Buy on Omega Therapeutics, Lowers Price Target to $7

Moomoo 24/7 ·  Apr 1 08:24

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and lowers the price target from $12 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment